- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Altering bioelectricity on inhibition of human breast cancer cells ; volume:16 ; number:1 ; day:22 ; month:9 ; year:2016 ; pages:1-9 ; date:12.2016
Cancer cell international ; 16, Heft 1 (22.9.2016), 1-9, 12.2016
- Creator
-
Berzingi, Seher
- Contributor
-
Newman, Mackenzie
Yu, Han-Gang
SpringerLink (Online service)
- DOI
-
10.1186/s12935-016-0348-8
- URN
-
urn:nbn:de:1111-2016102311850
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Berzingi, Seher
- Newman, Mackenzie
- Yu, Han-Gang
- SpringerLink (Online service)
Other Objects (12)
Altering cancer transcriptomes using epigenomic inhibitors
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
CDK4/6 inhibition in luminal breast cancer
Altering calcium influx for selective destruction of breast tumor
Altering phosphorylation in cancer through PP2A modifiers
Upregulation of CENPM promotes breast carcinogenesis by altering immune infiltration
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Selective inhibition of CDK9 in triple negative breast cancer
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
mTOR inhibition in management of advanced breast cancer
Altering cancer transcriptomes using epigenomic inhibitors
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
CDK4/6 inhibition in luminal breast cancer
Altering calcium influx for selective destruction of breast tumor
Altering phosphorylation in cancer through PP2A modifiers
Upregulation of CENPM promotes breast carcinogenesis by altering immune infiltration
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Selective inhibition of CDK9 in triple negative breast cancer
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex
mTOR inhibition in management of advanced breast cancer
Altering cancer transcriptomes using epigenomic inhibitors
EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth
CDK4/6 inhibition in luminal breast cancer
Altering calcium influx for selective destruction of breast tumor
Altering phosphorylation in cancer through PP2A modifiers
Upregulation of CENPM promotes breast carcinogenesis by altering immune infiltration
mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Bicarbonate and dichloroacetate: Evaluating pH altering therapies in a mouse model for metastatic breast cancer
Rad51 inhibition sensitizes breast cancer stem cells to PARP inhibitor in triple-negative breast cancer
Selective inhibition of CDK9 in triple negative breast cancer
Inhibition of breast cancer with transdermal tamoxifen-encapsulated lipoplex